[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Page 36681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-15517]



[[Page 36681]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 29, 2010, Alltech 
Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).......................  I
N-ethylamphetamine (1475)..................  I
N,N-dimethylamphetamine (1480).............  I
4-methylaminorex (cis isomer) (1590).......  I
Alpha-ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
4-methylaminorex (cis isomer) (1590).......  I
Alpha-ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
2,5-dimethoxy-4-(n)-                         I
 propylthiophenethylamine (7348).
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
4-bromo-2,5-dimethoxy-amphetamine (7391)...  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-methyl-2,5-dimethoxy-amphetamine (7395)..  I
2,5-dimethoxyamphetamine (7396)............  I
2,5-dimethoxy-4-ethylamphetamine (7399)....  I
3,4-methylenedioxy amphetamine (7400)......  I
N-hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-methylenedioxymethamphetamine (MDMA)     I
 (7405).
4-methoxyamphetamine (7411)................  I
Alpha-methyltryptamine (7432)..............  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
5-methoxy-N,N-diisopropyltryptamine (7439).  I
N-ethyl-1-phenylcyclohexylamine (7455).....  I
1-(1-phenylcyclohexyl)-pyrrolidine (7458)..  I
1-[1-(2-thienyl)-cyclohexyl]-piperidine      I
 (7470).
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Methamphetamine (1105).....................  II
1-phenylcyclohexylamine (7460)               II
 Phencyclidine (7471).
Phenylacetone (8501).......................  II
1-piperidinocyclohexanecarbonitrile (8603).  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Ecgonine (9180)............................  II
Meperidine intermediate-B (9233)...........  II
Noroxymorphone (9668)......................  II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical application only in clinical, toxicological, and 
forensic laboratories.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 27, 2010.

    Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-15517 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P